ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way

October 3, 1975

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

Chemical Carcinogenesis

November 18, 1994

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998